IP Library Granted Patent US 8,039,259
Granted Patent B2
US 8,039,259 · App. 11/931,996 · Granted Oct 18, 2011

Buffer solution for electroporation and a method comprising the use of the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,039,259
App. No.
11/931,996
Granted
Oct 18, 2011
Kind
B2
Abstract

A buffer solution for suspending animal or human cells and for dissolving biologically active molecules in order to introduce the biologically active molecules into the cells using electric current. The buffer solution includes at least one of sodium succinate, mannitol and sodium lactobionate. The buffer solution has a buffer capacity of at least 20 mmol*l −1 *pH −1 at a change in the from pH 7 to pH 8 and at a temperature of 25° C., and an ionic strength of at least 200 mmol * l −1 .

Claims (21)

1. A buffer solution for suspending animal or human cells and for dissolving biologically active molecules in order to introduce said biologically active molecules into the cells using electric current, the buffer solution consisting essentially of:

4-6 mM KCl,

10-20 mM MgCl 2 ,

5-25 mM HEPES,

50-160 mM Na 2 HPO 4 /NaH 2 PO 4 (at a pH of about 7.2), and

5-100 mM sodium lactobionate, and

wherein the buffer solution has a buffer capacity of at least 20 mmol * 1 −1 * pH −1 at a change in the pH from pH 7 to pH 8 and at a temperature of 25° C., and an ionic strength of at least 200 mmol * 1 −1 .

2. A buffer solution for suspending animal or human cells and for dissolving biologically active molecules in order to introduce said biologically active molecules into the cells using electric current, the buffer solution consisting essentially of:

4-6 mM KCl,

10-20 mM MgCl 2 ,

5-25 mM HEPES,

50-160 mM Na 2 HPO 4 /NaH 2 PO 4 (at a pH of about 7.2), and

5-100 mM mannitol, and

wherein the buffer solution has a buffer capacity of at least 20 mmol*l −1 *pH −1 at a change in the pH from pH 7 to pH 8 and at a temperature of 25° C., and an ionic strength of at least 200 mmol*l −1 .

3. A buffer solution for suspending animal or human cells and for dissolving biologically active molecules in order to introduce said biologically active molecules into the cells using electric current, the buffer solution consisting essentially of:

4-6 mM KCl,

10-20 mM MgCl 2 ,

5-25 mM HEPES,

50-160 mM Na 2 HPO 4 /NaH 2 PO 4 (at a pH of about 7.2), and

5-100 mM sodium succinate,and

wherein the buffer solution has a buffer capacity of at least 20 mmol*l −1 *pH −1 at a change in the pH from pH 7 to pH 8 and at a temperature of 25° C., and an ionic strength of at least 200 mmol*l −1 .

Assignments (3)
CHANGE OF LEGAL FORM Recorded May 13, 2011
From: LONZA COLOGNE AG
To: LONZA COLOGNE GMBH
Reel/Frame 026276/0125 →
CHANGE OF LEGAL FORM Recorded Feb 3, 2011
From: LONZA COLOGNE AG
To: LONZA COLOGNE GMBH
Reel/Frame 025741/0888 →
CHANGE OF NAME Recorded Jun 18, 2009
From: AMAXA AG
To: LONZA COLOGNE AG
Reel/Frame 022846/0012 →